These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28343366)

  • 1. Motor learning in animal models of Parkinson's disease: Aberrant synaptic plasticity in the motor cortex.
    Xu T; Wang S; Lalchandani RR; Ding JB
    Mov Disord; 2017 Apr; 32(4):487-497. PubMed ID: 28343366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic rewiring of neural circuits in the motor cortex in mouse models of Parkinson's disease.
    Guo L; Xiong H; Kim JI; Wu YW; Lalchandani RR; Cui Y; Shu Y; Xu T; Ding JB
    Nat Neurosci; 2015 Sep; 18(9):1299-1309. PubMed ID: 26237365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early, severe and bilateral loss of LTP and LTD-like plasticity in motor cortex (M1) in de novo Parkinson's disease.
    Kishore A; Joseph T; Velayudhan B; Popa T; Meunier S
    Clin Neurophysiol; 2012 Apr; 123(4):822-8. PubMed ID: 21945457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant learning in Parkinson's disease: A neurocomputational study on bradykinesia.
    Ursino M; Baston C
    Eur J Neurosci; 2018 Jun; 47(12):1563-1582. PubMed ID: 29786160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic modulation of primary motor cortex: From cellular and synaptic mechanisms underlying motor learning to cognitive symptoms in Parkinson's disease.
    Cousineau J; Plateau V; Baufreton J; Le Bon-Jégo M
    Neurobiol Dis; 2022 Jun; 167():105674. PubMed ID: 35245676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. History of exposure to dopaminergic medication does not affect motor cortex plasticity and excitability in Parkinson's disease.
    Kačar A; Filipović SR; Kresojević N; Milanović SD; Ljubisavljević M; Kostić VS; Rothwell JC
    Clin Neurophysiol; 2013 Apr; 124(4):697-707. PubMed ID: 23085389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of neuroplasticity in dopaminergic therapy for Parkinson disease.
    Zhuang X; Mazzoni P; Kang UJ
    Nat Rev Neurol; 2013 May; 9(5):248-56. PubMed ID: 23588357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Synaptic Remodeling by Dopamine in Direct and Indirect Striatal Projection Neurons in Pitx3
    Suarez LM; Alberquilla S; García-Montes JR; Moratalla R
    J Neurosci; 2018 Apr; 38(15):3619-3630. PubMed ID: 29483281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor cortex plasticity and excitability in Parkinson's disease.
    Bareš M; Kaňovský P; Rektor I
    Clin Neurophysiol; 2014 Oct; 125(10):2135-6. PubMed ID: 24631014
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to "motor cortex plasticity and excitability in Parkinson's disease".
    Filipović SR
    Clin Neurophysiol; 2014 Oct; 125(10):2136-7. PubMed ID: 24618213
    [No Abstract]   [Full Text] [Related]  

  • 11. Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease.
    Lindenbach D; Bishop C
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 2):2737-50. PubMed ID: 24113323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunction of motor cortices in Parkinson's disease.
    Chu HY; Smith Y; Lytton WW; Grafton S; Villalba R; Masilamoni G; Wichmann T
    Cereb Cortex; 2024 Jul; 34(7):. PubMed ID: 39066504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute dopamine boost has a negative effect on plasticity of the primary motor cortex in advanced Parkinson's disease.
    Kishore A; Popa T; Velayudhan B; Joseph T; Balachandran A; Meunier S
    Brain; 2012 Jul; 135(Pt 7):2074-88. PubMed ID: 22609619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spike-timing-related plasticity is preserved in Parkinson's disease and is enhanced by dopamine: evidence from transcranial magnetic stimulation.
    Rodrigues JP; Walters SE; Stell R; Mastaglia FL; Thickbroom GW
    Neurosci Lett; 2008 Dec; 448(1):29-32. PubMed ID: 18952149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine Promotes Motor Cortex Plasticity and Motor Skill Learning via PLC Activation.
    Rioult-Pedotti MS; Pekanovic A; Atiemo CO; Marshall J; Luft AR
    PLoS One; 2015; 10(5):e0124986. PubMed ID: 25938462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress and corticosterone alter synaptic plasticity in a rat model of Parkinson's disease.
    Hao Y; Shabanpoor A; Metz GA
    Neurosci Lett; 2017 Jun; 651():79-87. PubMed ID: 28473257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preservation of function in Parkinson's disease: what's learning got to do with it?
    Beeler JA
    Brain Res; 2011 Nov; 1423():96-113. PubMed ID: 22000081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic and cellular plasticity in Parkinson's disease.
    Chu HY
    Acta Pharmacol Sin; 2020 Apr; 41(4):447-452. PubMed ID: 32112041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor learning and metaplasticity in striatal neurons: relevance for Parkinson's disease.
    Giordano N; Iemolo A; Mancini M; Cacace F; De Risi M; Latagliata EC; Ghiglieri V; Bellenchi GC; Puglisi-Allegra S; Calabresi P; Picconi B; De Leonibus E
    Brain; 2018 Feb; 141(2):505-520. PubMed ID: 29281030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-DOPA and cortical associative plasticity in Parkinson's disease.
    Suppa A; Bologna M; Berardelli A
    Clin Neurophysiol; 2013 Apr; 124(4):638-9. PubMed ID: 23218186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.